|
Volumn 49, Issue 5, 2004, Pages 22-26
|
Reactogenicity, safety and immonogenicity of a recombinant bivaccine against smallpox and hepatitis B in limited clinical trials
a a a a a a a a a a a a a a a a
a
NONE
|
Author keywords
Cell immunity; Clinical trials; Humoral immunity; Long tern revaccination; Oral recombinant variola and hepatitis B bivaccine as tablets; Primary vaccination; Reactogenicity; Safety
|
Indexed keywords
HEPATITIS B VACCINE;
RECOMBINANT VACCINE;
SMALLPOX VACCINE;
CHICKENPOX VACCINE;
HEPATITIS B ANTIGEN;
VIRUS ANTIBODY;
ANTIGEN EXPRESSION;
ARTICLE;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
DRUG MEGADOSE;
DRUG SAFETY;
HEPATITIS B;
HUMAN;
HUMORAL IMMUNITY;
IMMUNE RESPONSE;
IMMUNOGENICITY;
IMMUNOREACTIVITY;
LOW DRUG DOSE;
REVACCINATION;
RISK ASSESSMENT;
SMALLPOX;
TABLET FORMULATION;
VIRUS STRAIN;
VIRUS VECTOR;
ADULT;
BIOSYNTHESIS;
COMPARATIVE STUDY;
DOSE RESPONSE;
FEMALE;
FEVER;
IMMUNOLOGY;
LYMPHADENITIS;
MALE;
ORAL DRUG ADMINISTRATION;
TABLET;
VACCINATION;
VACCINIA;
VARIOLA;
VARIOLA VIRUS;
ADMINISTRATION, ORAL;
ADULT;
ANTIBODIES, VIRAL;
CHICKENPOX VACCINE;
DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC;
FEMALE;
FEVER;
HEPATITIS B;
HEPATITIS B ANTIGENS;
HEPATITIS B VACCINES;
HUMANS;
LYMPHADENITIS;
MALE;
SMALLPOX;
TABLETS;
VACCINATION;
VACCINES, SYNTHETIC;
VACCINIA;
|
EID: 7244245418
PISSN: 05074088
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (13)
|